Biomx Inc PHGE:NYSE American

RT Quote | Last NYSE Arca, VOL From CTA | USD
Last | 4:00 PM EDT
0.3546quote price arrow down-0.0054 (-1.50%)
Volume
38,973
52 week range
0.19 - 0.86
Loading...
  • Open0.375
  • Day High0.375
  • Day Low0.3401
  • Prev Close0.36
  • 52 Week High0.86
  • 52 Week High Date03/06/24
  • 52 Week Low0.19
  • 52 Week Low Date02/29/24

Key Stats

  • Market Cap19.581M
  • Shares Out55.22M
  • 10 Day Average Volume0.30M
  • Dividend-
  • Dividend Yield-
  • Beta1.33
  • YTD % Change26.64

KEY STATS

  • Open0.375
  • Day High0.375
  • Day Low0.3401
  • Prev Close0.36
  • 52 Week High0.86
  • 52 Week High Date03/06/24
  • 52 Week Low0.19
  • 52 Week Low Date02/29/24
  • Market Cap19.581M
  • Shares Out55.22M
  • 10 Day Average Volume0.30M
  • Dividend-
  • Dividend Yield-
  • Beta1.33
  • YTD % Change26.64

RATIOS/PROFITABILITY

  • EPS (TTM)-0.54
  • P/E (TTM)-0.65
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-24.477M
  • ROE (TTM)-216.99%
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)363.10%

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Biomx Inc

 

Profile

MORE
BiomX Inc., formerly Chardan Healthcare Acquisition Corp., is a microbiome company. The Company is focused on developing both natural and engineered phage therapies. It develops therapies to target and destroy bacteria that affect the appearance of skin, as well as harmful bacteria in chronic diseases, such as inflammatory bowel disease (IBD), primary sclerosing cholangitis (PSC) and cancer. The Company discovers and validates bacterial targets and customizes phage...
Russell Greig Ph.D.
Independent Chairman of the Board
Jonathan Solomon
Chief Executive Officer, Director
Marina Wolfson CPA
Chief Financial Officer
Address
22 Einstein St., Floor 4
Ness-ziona
7414003
Israel